Neovacs appoints Piers Whitehead as VP of Corporate Development

03-Sep-2009 - France

Neovacs announced that Piers Whitehead has joined the Company`s management team as VP Corporate Development. Mr Whitehead has over 15 years experience in the Life Sciences as both a senior executive and a consultant, and has led and negotiated transactions in Europe, the US, Japan and Korea.

Prior to joining Neovacs, Mr. Whitehead was a consultant providing counsel to biotechnology companies on business and corporate development. Previously, he was Vice President of Business and Corporate Development for VaxGen Inc., a public US biotechnology company, and prior to that he was a Vice President of Mercer Management Consulting (now Oliver Wyman), where he headed that firm’s San Francisco office. He graduated from Oriel College, Oxford.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances